MESOTHELIOMA

Portada » MESOTHELIOMA
PROMISE-Meso

Multicentre randomised phase III trial comparing pembrolizumab versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma.

Promotor: ETOP
Coordinador en España: Dr. Ernest Nadal

Centros participantes
  • Institut Català d’Oncologia-Hospitalet
  • Hospital Clínico Universitario de Valladolid
  • Hospital Teresa Herrera, A Coruña

Switch The Language

Award winning creative agency

We are building for tomorrow because tomorrow is the future and we want to make a contribution to the wonderful digital age that is awaiting us.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.